This was stated by Leo in the 12/26 PR about the UC P1 trial.
The only positive outcome for the company that I can come up with is a deal. Anybody got any other ideas?
“The study is expected to be a quick one, with dosing completed within several weeks of commencement, and, if successful, would translate into numerous potential positive outcomes for the company,” noted Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals.
The only positive outcome for the company that I can come up with is a deal. Anybody got any other ideas?
“The study is expected to be a quick one, with dosing completed within several weeks of commencement, and, if successful, would translate into numerous potential positive outcomes for the company,” noted Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Leo Took The Money and Ran